HARSAUL FOUNDATION sold 15.2% of their position (3.42M shares) of RVL PHARMACEUTICALS PLC on the open market
Open‑market sale worth $221.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2023ACC: 0001754526-23-000001
10% Owner
Since Oct 2018
-3.42M
Net shares
Net seller
$221.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.42M disposed
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
−3.42M
Price / share
$0.06
Trade value
$221.03K
% of position
15.2%
10/18/2023
22.49M→19.06M
Total
Net shares
−3.42M
Net value
-$221.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 10/18/2023 | S · Sale | −3.42M | $0.06 | $221.03K | 15.2% | 22.49M | 19.06M |
| Total | −3.42M | -$221.03K | ||||||
Derivative Transactions0
No derivative transactions reported